Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

April 25, 2024 08:05 ET | Source: Shareholder Capital LLC

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals

Shareholder Capital Delivers Letter to Independent Members of the Board of Vanda Pharmaceuticals
July 23, 2021 15:26 ET | Source: Bragar Eagel & Squire

Notice of Settlement of Derivative Suit

NEW YORK, July 23, 2021 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire P.C. announces the proposed settlement of the derivative action captioned In re Vanda Pharmaceuticals Inc. Derivative...
April 25, 2019 10:00 ET | Source: Schall Law

FRIDAY DEADLINE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, April 25, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Vanda Pharmaceuticals Inc....
April 17, 2019 16:11 ET | Source: Block & Leviton LLP

A Securities Class Action Has Been Filed Against Vanda; Block & Leviton LLP Encourages Shareholders to Contact the Firm

BOSTON, April 17, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, informs investors that there has been a class...
March 26, 2019 14:58 ET | Source: Zhang Investor Law P.C.

VNDA DEADLINE: Zhang Investor Law Reminds of Deadline in Class Action Against Vanda Pharmaceuticals Inc. – VNDA

NEW YORK, March 26, 2019 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Vanda Pharmaceuticals Inc. (NASDAQ:...
March 20, 2019 20:47 ET | Source: Pawar Law Group

SHAREHOLDER ALERT: Pawar Law Group Announces a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA

NEW YORK, March 20, 2019 (GLOBE NEWSWIRE) -- Pawar Law Group announces that a class action lawsuit has been filed on behalf of shareholders who purchased shares of Vanda Pharmaceuticals Inc....
March 12, 2019 16:44 ET | Source: Zhang Investor Law P.C.

VNDA ALERT: Zhang Investor Law Announces the Filing of a Securities Class Action Lawsuit Against Vanda Pharmaceuticals Inc. – VNDA

NEW YORK, March 12, 2019 (GLOBE NEWSWIRE) -- Zhang Investor Law announces the filing of a class action lawsuit on behalf of shareholders who bought shares of Vanda Pharmaceuticals Inc. (NASDAQ:...
March 05, 2019 14:52 ET | Source: Schall Law

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, March 05, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Vanda Pharmaceuticals Inc....
February 14, 2019 15:00 ET | Source: Schall Law

ONGOING INVESTIGATION: The Schall Law Firm Announces it is Investigating Claims Against Vanda Pharmaceuticals Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm

LOS ANGELES, Feb. 14, 2019 (GLOBE NEWSWIRE) -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Vanda...
February 11, 2019 10:49 ET | Source: Block & Leviton LLP

Vanda Pharmaceuticals Inc. Investigated by Block & Leviton LLP For Violations of Federal Securities Laws

BOSTON, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Vanda Pharmaceuticals...